Evidence map›Paper›PMID 37643591›Full record

ArticleInorganic chemistry2023

Radiometal-Labeled Photoactivatable Pt(IV) Anticancer Complex for Theranostic Phototherapy.

Cinzia Imberti, Jamie Lok, James P C Coverdale, Oliver W L Carter, Millie E Fry, Miles L Postings, Jana Kim, George Firth, Philip J Blower, Peter J Sadler

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Inorganic chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Cinzia ImbertiDepartment of Chemistry, University of Warwick, Coventry CV4 7AL, U.K.ORCID 0000-0003-1187-7951
Jamie LokDepartment of Chemistry, University of Warwick, Coventry CV4 7AL, U.K.
James P C CoverdaleSchool of Pharmacy, Institute of Clinical Sciences, University of Birmingham, Birmingham B15 2TT, U.K.ORCID 0000-0002-7779-6620
Oliver W L CarterDepartment of Chemistry, University of Warwick, Coventry CV4 7AL, U.K.
Millie E FrySchool of Pharmacy, Institute of Clinical Sciences, University of Birmingham, Birmingham B15 2TT, U.K.
Miles L PostingsDepartment of Chemistry, University of Warwick, Coventry CV4 7AL, U.K.ORCID 0000-0003-4933-3052
Jana KimSchool of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, London SE1 7EH, U.K.ORCID 0000-0003-4386-440X
George FirthSchool of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, London SE1 7EH, U.K.ORCID 0000-0003-1603-5067
Philip J BlowerSchool of Biomedical Engineering & Imaging Sciences, King's College London, St Thomas' Hospital, London SE1 7EH, U.K.ORCID 0000-0001-6290-1590
Peter J SadlerDepartment of Chemistry, University of Warwick, Coventry CV4 7AL, U.K.ORCID 0000-0001-9160-1941
University of Warwick · GBSt Thomas' Hospital · GBUniversity of Birmingham · GB

Funding

Wellcome Trust 209173/Z/17/Z
6 · The paper itself

Abstract

A novel photoactivatable Pt(IV) diazido anticancer agent,

Indexed as

Ferric CompoundsGallium RadioisotopesAnimalsCell Line, TumorHumansMicePhototherapyPositron-Emission TomographyPrecision MedicineTissue DistributionZirconiumFerric CompoundsGallium RadioisotopesZirconium

Identifiers

PMID37643591
PMCPMC10731635
OpenAlexW4386241170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.